Source:http://linkedlifedata.com/resource/pubmed/id/10988120
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
2000-10-12
|
pubmed:abstractText |
Genes for the chemokine receptors CCR5 and CCR2 are characterized by polymorphisms resulting in a nonfunctional receptor expression. Ligands for CCR2 and CCR5 (chemokines monocyte chemotactic protein-1 [MCP-1] and RANTES) are implicated in the pathogenesis of sarcoidosis. We have, therefore, analyzed polymorphisms of CCR5 (32-bp deletion in CCR5 gene [Delta32]) and of CCR2 (replacement of valine by isoleucine in CCR2 gene [64I]) in 66 Czech patients with sarcoidosis in comparison with a representative sample of Czech normal population. The frequencies of CCR5Delta32 and CCR2-64I polymorphisms in patients with sarcoidosis were different from that in control subjects. CCR5Delta32 allelic frequency was significantly increased in patients. By contrast, the CCR2-64I allele was more frequent in control subjects; however, the difference did not attain significance. Interestingly, the CCR5Delta32 allele was associated with clinically more apparent disease: it was present in 39.1% of patients requiring corticosteroids but only in 16.7% patients who did not need therapeutic intervention (odds ratio [OR] = 2.9). When patients requiring corticosteroids were compared with control subjects, the differences in the CCR5Delta32 frequencies were enhanced (p < 0.01). In conclusion, the observed association of CCR5Delta32 and CCR2-64I with sarcoidosis implicates a role for these polymorphisms in disease susceptibility and protection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCR2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CCR5,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Chemokine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytokine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1073-449X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1000-3
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10988120-Adolescent,
pubmed-meshheading:10988120-Adult,
pubmed-meshheading:10988120-Aged,
pubmed-meshheading:10988120-Czech Republic,
pubmed-meshheading:10988120-Female,
pubmed-meshheading:10988120-Genetic Predisposition to Disease,
pubmed-meshheading:10988120-Humans,
pubmed-meshheading:10988120-Male,
pubmed-meshheading:10988120-Middle Aged,
pubmed-meshheading:10988120-Polymorphism, Genetic,
pubmed-meshheading:10988120-Prognosis,
pubmed-meshheading:10988120-Receptors, CCR2,
pubmed-meshheading:10988120-Receptors, CCR5,
pubmed-meshheading:10988120-Receptors, Chemokine,
pubmed-meshheading:10988120-Receptors, Cytokine,
pubmed-meshheading:10988120-Sarcoidosis
|
pubmed:year |
2000
|
pubmed:articleTitle |
CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.
|
pubmed:affiliation |
Departments of Immunology and Respiratory Medicine, PalackýUniversity, Olomouc, Czech Republic. petrekm@fnol.cz
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|